Wednesday 14, Dec 2011
Pale skinned people and those taking steroids at risk of Vitamin D deficiency
People with pale skin who are prone to sunburn may need to take vitamin D supplements, according to experts.
Experts increasingly believe that vitamin D levels below 60nmol/L may also be damaging to health.
From Activequote.com:
Vitamin D is important for good health, growth and strong bones and teeth. It can naturally be obtained by sunlight, but is also found in oily fish, eggs, and fortified foods.
Low levels of the vitamin have been linked with poorer survival rates from breast cancer and conditions such as multiple sclerosis.
Vitamin D supplements are already recommended for people who wear full body covering, people with darker skin, and vulnerable groups like the elderly, young and pregnant.
This is the first time fair skinned people have been included in this group. The study, funded by Cancer Research UK, indicated that pale skinned people may not be able to make enough of the vitamin from sunlight.
The study appeared in the journal of Clinical Endocrinology and Metabolism.
Tags: multiple sclerosis, supplements
Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids
Interferon, an immune-system protein already used for treating health complications like hepatitis C, multiple sclerosis, and a variety of cancers, could be used for granting relief to patients afflicted with asthma.
A factor (protein) in the human eye may prove effective to prevent and halt autoimmune eye disease in animal models besides useful for preventing and treating other autoimmune diseases, including multiple sclerosis and diabetes, as per scientists at the
Disease activity related with multiple sclerosis (MS) is reduced to a considerable extent when a combination of
The use of a
The addition of a
When steroid drugs are added to multiple sclerosis (MS) treatment, the risk of disease activity gets reduced to a considerable extent as per a study presented as a part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle.
The Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark conducted a study of adding methylprednisolone in the treatment of 